Oral GLP-1 vs injection: which works better? Experts explain why injections still lead in weight loss—and how new oral ...
Glucagon-like peptide-1 (GLP-1) medications are now available as a pill for weight loss, offering another option beyond ...
The FDA approved Wegovy HD, a higher-dose semaglutide for weight loss in adults with obesity, offering greater weight ...
If you've been following the weight-loss medication revolution, you've likely heard about Wegovy injections. But now there's ...
The U.S. Food and Drug Administration has approved a new dose of the GLP-1 class weight loss drug Wegovy that’s three times ...
This year's catalysts in the space include a near-term FDA decision on Eli Lilly’s oral challenger to the new Wegovy pill.
Morning Overview on MSN
The biggest GLP-1 drug mistake, and how to avoid it
The FDA has spent much of 2025 issuing warnings about a single, recurring problem with GLP-1 weight loss drugs: patients and ...
Last week’s expiry of the patent for semaglutide—the active ingredient in Novo Nordisk’s blockbuster drugs Wegovy and Ozmepic ...
The FDA approves Wegovy HD (semaglutide 7.2 mg) for chronic weight management in adults with obesity or overweight and weight-related conditions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results